Lenvatinib

Red

Brand Name(s):Lenvima/ Kisplyx

Indication:Hepatocellular carcinoma
Differentiated thyroid carcinoma (DTC), refractory to radioactive iodine (RAI). Progressive, locally advanced or metastatic/
Renal cell carcinoma (advanced)

Rationale:1,2,3

Considered:Jun-15

Review Date:Aug-23

Comments: